Roswell Park Comprehensive Cancer CenterCancer Center Expands Lung Cancer Screening Program by Leveraging AI Software to Track and Manage Eligible Patients
06 Mar 2024
DENVER, March 6, 2024 /PRNewswire/ -- Based in Upstate New York, Roswell Park Comprehensive Cancer CenterCancer Center is intensifying its efforts to increase lung cancer screenings in the greater Buffalo area by partnering with Denver-based Eon, a leading health-tech company, to leverage its proprietary artificial intelligence patient management software.
Continue Reading
Preview
Source: PRNewswire
Roswell Park Comprehensive Cancer CenterCancer Center Expands Lung Cancer Screening Program by Leveraging AI Software to Track and Manage Eligible Patients
According to the American Lung Association, 44% of lung cancer cases are not caught until a late stage, when the survival rate is only 8%. In New York State, only 6% of people eligible are being screened for lung cancer, which is a simple low-dose CT exam, and can be crucial to early detection and treatment. In late 2022, Roswell Park launched an initiative to reduce barriers to care and reach more patients by deploying a lung screening program on wheels to provide greater access in both the rural and urban communities they serve. In leveraging Eon Patient Management (EPM) to longitudinally track and manage lung cancer screening patients, Roswell Park will be able to improve outcomes by ensuring more patients return for guideline-driven follow-up care.
Lung cancer screening can be laborious and time-consuming and often entails significant manual data entry. Eon's lung cancer screening (LCS) patient management platform uses advanced AI to automate routine administrative tasks, without interrupting radiology workflows. Care teams are then able to focus on patients with significant findings while automating communication and follow-up care for low-risk patients. This not only improves patient care but will significantly broaden their LCS program's bandwidth and increase patient adherence to annual screenings.
"Knowing that Eon's lung cancer screening solution will allow us to enroll and screen more eligible patients, and hopefully catch cancer early, gave us the unique opportunity to receive a grant from the state of New York to fund this initiative," said Mary Reid, Chief of Cancer Screening and Survivorship at Roswell Park Comprehensive Cancer CenterCancer Center. "We know there are thousands more patients who should be screened and aren't. As the only National Cancer Institute-designated comprehensive cancer center in Upstate New York, we must ensure we have superior solutions in place to provide patients with the best care."
About Eon
Eon is a health data science company that utilizes computational linguistics, workflow automation, and tech-enabled virtual navigation services to track incidental findings across a variety of medical disciplines throughout the course of a patient's health journey. Eon exists to ensure the right data reaches the right people at the right time to make patients healthier and health care affordable.
About Roswell Park Comprehensive Cancer CenterCancer Center
From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer CenterCancer Center generates innovations that shape how cancer is detected, treated, and prevented worldwide. Driven to eliminate cancer's grip on humanity, the Roswell Park team of 4,000 makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Founded in 1898, Roswell Park was among the first three cancer centers nationwide to become a National Cancer Institute-designated comprehensive cancer center and is the only one to hold this designation in Upstate New York.
Media Contact:
Candice Chan
9787930426
374009@email4pr.com
SOURCE Eon
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.